Fentanyl Citrate is Used for managing breakthrough pain in cancer patients who are already receiving and tolerant to opioid therapy. It was first introduced by Rising Pharma Holdings Inc in its drug Sublimaze Preservative Free on Approved Prior to Jan 1, 1982. Other drugs containing Fentanyl Citrate are Actiq, Onsolis, Fentanyl Citrate, Fentora, Abstral, Fentanyl, Lazanda. 16 different companies have introduced drugs containing Fentanyl Citrate.

Fentanyl Citrate Patents

Given below is the list of patents protecting Fentanyl Citrate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Lazanda	US9731869	Container	Jan 26, 2032	Btcp Pharma
Fentora	US7862832	Generally linear effervescent oral fentanyl dosage form and methods of administering	Jun 15, 2028	Cephalon
Fentora	US7862833	Effervescent oral opiate dosage forms and methods of administering opiates	Jun 15, 2028	Cephalon
Onsolis	US9579288	Tesofensine and beta blocker combination formulations	Jul 23, 2027	Adalvo
Onsolis	US9597288	Transmucosal delivery devices with enhanced uptake	Jul 23, 2027	Adalvo
Fentora	US8092832	Generally linear effervescent oral fentanyl dosage form and methods of administering	Dec 30, 2024 (Expired)	Cephalon
Fentora	US8119158	Effervescent oral fentanyl dosage form and methods of administering fentanyl	Dec 30, 2024 (Expired)	Cephalon
Lazanda	US8216604	Method of managing or treating pain	Oct 03, 2024 (Expired)	Btcp Pharma
Lazanda	US8889176	Method of managing or treating pain	Jan 16, 2024 (Expired)	Btcp Pharma
Lazanda	US9078814	Intranasal spray device containing pharmaceutical composition	Jan 08, 2024 (Expired)	Btcp Pharma
Lazanda	US9814705	Intranasal spray device containing pharmaceutical composition	Jan 08, 2024 (Expired)	Btcp Pharma
Onsolis	US7579019	Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces	Jan 22, 2020 (Expired)	Adalvo
Abstral	US6759059	Fentanyl composition for the treatment of acute pain	Sep 24, 2019 (Expired)	Sentynl Theraps Inc
Abstral	US6761910	Pharmaceutical composition for the treatment of acute disorders	Sep 24, 2019 (Expired)	Sentynl Theraps Inc
Abstral	US7910132	Pharmaceutical composition for the treatment of acute disorders	Sep 24, 2019 (Expired)	Sentynl Theraps Inc
Fentora	US6200604	Sublingual buccal effervescent	Mar 26, 2019 (Expired)	Cephalon
Fentora	US6974590	Sublingual buccal effervescent	Mar 26, 2019 (Expired)	Cephalon
Fentora	US8728441	Sublingual buccal effervescent	Mar 26, 2019 (Expired)	Cephalon
Fentora	US8753611	Sublingual buccal effervescent	Mar 26, 2019 (Expired)	Cephalon
Fentora	US8765100	Transmucosal effervescent	Mar 26, 2019 (Expired)	Cephalon
Lazanda	US6432440	Pectin compositions and methods of use for improved delivery of drugs to mucosal surfaces	Apr 20, 2018 (Expired)	Btcp Pharma
Onsolis	US6159498	Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces	Oct 18, 2016 (Expired)	Adalvo

Add above patents to watchlist

Fentanyl Citrate's Family Patents

Full family tree

Fentanyl Citrate Generic API Manufacturers

Several generic applications have been filed for Fentanyl Citrate. The first generic version for Fentanyl Citrate was by Abbott Laboratories Hosp Products Div and was approved on Apr 30, 1990. And the latest generic version is by Dr Reddys Laboratories Sa and was approved on Aug 22, 2022.

Given below is the list of companies who have filed for Fentanyl Citrate generic, along with the locations of their manufacturing plants worldwide.